Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis
Authors:
- En-Guang BiEBEn-Guang Bi
- Yang-Tong LouYLYang-Tong Lou
- Xiao-Dong WuXWXiao-Dong Wu
- Zhi-Duo LiuZLZhi-Duo Liu
- Jia ZhouJZJia Zhou
- Yuan WangYWYuan Wang
- Zhao MaZMZhao Ma
- Guo-Mei LinGLGuo-Mei Lin
- Shu-Hui SunSSShu-Hui Sun
- Chao BianCBChao Bian
- Ai-Zhong ChenACAi-Zhong Chen
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (1) , 1093-1098
Abstract
No abstract availableKeywords
Funding Information
- NSFC (90713044, 20621062)
- Chinese Academy of Sciences
- Shanghai Municipal Commission of Sciences and Technology (07DZ22001, 08431903001, 08431903004)
- E-institutes of Shanghai Universities Immunology Division and Chemical Biology
This publication has 28 references indexed in Scilit:
- IL-21 initiates an alternative pathway to induce proinflammatory TH17 cellsNature, 2007
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cellsNature Immunology, 2006
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisJournal of Experimental Medicine, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- Multiple sclerosisJournal of Clinical Investigation, 2004
- Multiple sclerosis: a two-stage diseaseNature Immunology, 2001